Related Experiment Video
Updated: Dec 5, 2025
Using a Bipolar Electrode to Create a Temporal Lobe Epilepsy Mouse Model by Electrical Kindling of the Amygdala
Published on: June 29, 2022
High concordance between hippocampal transcriptome of the mouse intra-amygdala kainic acid model and human temporal
Giorgia Conte1, Alberto Parras1,2,3,4, Mariana Alves1
1Department of Physiology and Medical Physics, Royal College of Surgeons in Ireland, University of Medicine and Health Sciences, Dublin, Ireland.
Objective:
Pharmacoresistance and the lack of disease-modifying actions of current antiseizure drugs persist as major challenges in the treatment of epilepsy. Experimental models of chemoconvulsant-induced status epilepticus remain the models of choice to discover potential antiepileptogenic drugs, but doubts remain as to the extent to which they model human pathophysiology. The aim of the present study was to compare the molecular landscape of the intra-amygdala kainic acid model of status epilepticus in mice with findings in resected brain tissue from patients with drug-resistant temporal lobe epilepsy (TLE).
Methods:
Status epilepticus was induced via intra-amygdala microinjection of kainic acid in C57BL/6 mice, and gene expression was analyzed via microarrays in hippocampal tissue at acute and chronic time-points. Results were compared to reference datasets in the intraperitoneal pilocarpine and intrahippocampal kainic acid model and to human resected brain tissue (hippocampus and cortex) from patients with drug-resistant TLE.
Results:
Intra-amygdala kainic acid injection in mice triggered extensive dysregulation of gene expression that was ~3-fold greater shortly after status epilepticus (2729 genes) when compared to epilepsy (412). Comparison to samples from patients with TLE revealed a particularly high correlation of gene dysregulation during established epilepsy. Pathway analysis found suppression of calcium signaling to be highly conserved across different models of epilepsy and patients. cAMP response element-binding protein (CREB) was predicted as one of the main upstream transcription factors regulating gene expression during acute and chronic phases, and inhibition of CREB reduced seizure severity in the intra-amygdala kainic acid model.
Significance:
Our findings suggest the intra-amygdala kainic acid model faithfully replicates key molecular features of human drug-resistant TLE and provides potential rational target approaches for disease-modification through new insights into the unique and shared gene expression landscape in experimental epilepsy.
Insights
This study validates the intra-amygdala kainic acid mouse model for epilepsy research, showing it mirrors molecular changes in human drug-resistant temporal lobe epilepsy (TLE). Findings offer new targets for disease-modifying epilepsy treatments.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- Epilepsy treatment faces challenges due to drug resistance and lack of disease-modifying therapies.
- Current experimental epilepsy models are crucial for discovering new antiepileptogenic drugs but their human relevance is debated.
Purpose of the Study:
- To compare the molecular profile of the intra-amygdala kainic acid-induced status epilepticus mouse model with human drug-resistant temporal lobe epilepsy (TLE).
- To assess the validity of this mouse model in replicating key molecular features of human epilepsy.
Main Methods:
- Status epilepticus was induced in mice using intra-amygdala kainic acid.
- Gene expression was analyzed using microarrays in hippocampal tissue at acute and chronic stages.
- Results were compared with other epilepsy models and human TLE brain tissue.
Main Results:
- Intra-amygdala kainic acid induced significant gene expression dysregulation in mice, with more genes affected acutely than chronically.
- A high correlation in gene dysregulation was observed between the mouse model and human TLE samples, especially in established epilepsy.
- Suppression of calcium signaling was a conserved pathway, and CREB was identified as a key upstream regulator, with its inhibition reducing seizure severity.
Conclusions:
- The intra-amygdala kainic acid mouse model accurately reflects molecular aspects of human drug-resistant TLE.
- This model offers a valuable platform for identifying disease-modifying therapeutic targets in epilepsy.
- Understanding the shared and unique gene expression landscapes can guide the development of novel epilepsy treatments.
